Behavioral changes and mitochondrial dysfunction in a rat model of schizophrenia induced by ketamine

Metabolic Brain Disease

Volumn 26, Issue 1, 2011, Pages 69-77

  De Oliveira, Larissa ^a   Fraga, Daiane B ^a   De Luca, Renata D ^a   Canever, Leila ^a   Ghedim, Fernando V ^a   Matos, Maria Paula P ^a   Streck, Emilio L ^a   Quevedo, João ^a   Zugno, Alexandra I ^a  

^a UNIVERSITY OF SOUTHERN SANTA CATARINA   (Brazil)

Author keywords

Behavior; Ketamine; Mitochondrial respiratory chain; Schizophrenia

Indexed keywords

KETAMINE; MITOCHONDRIAL ENZYME;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEHAVIOR CHANGE; CONTROLLED STUDY; CORPUS STRIATUM; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DRUG INDUCED DISEASE; ENZYME ACTIVITY; HIPPOCAMPUS; LOCOMOTION; MALE; NONHUMAN; OPEN FIELD TEST; PREFRONTAL CORTEX; RAT; RESPIRATORY CHAIN; SCHIZOPHRENIA; STEREOTYPY;

ANIMALS; BRAIN; DISEASE MODELS, ANIMAL; ELECTRON TRANSPORT; ELECTRON TRANSPORT COMPLEX I; ELECTRON TRANSPORT COMPLEX II; ELECTRON TRANSPORT COMPLEX III; ELECTRON TRANSPORT COMPLEX IV; HUMANS; KETAMINE; MALE; MITOCHONDRIA; RATS; RATS, WISTAR; RECEPTORS, N-METHYL-D-ASPARTATE; SCHIZOPHRENIA; TIME FACTORS; TISSUE DISTRIBUTION;

ANIMALIA; RATTUS;

EID: 79955107011     PISSN: 08857490     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11011-011-9234-1     Document Type: Article

References (50)

1. JJ Battisti CB Shreffler NJ Uretsky LJ Wallace 2000 NMDA antagonists block expression of sensitization of amphetamine-and apomorphuneinduced stereotypy Pharmacol Biochem Behav 67 241 246 10.1016/S0091-3057(00)00324-5 11124387 10.1016/S0091-3057(00)00324-5 1:CAS:528:DC%2BD3cXovFKjs7k%3D (Pubitemid 32000829)
2. A Becker B Peters H Schroeder T Mann G Huether G Grecksch 2003 Ketamine-induced changes in rat behavior: a possible animal model of schizophrenia Prog Neuropsychopharmacol Biol Psychiatry 27 687 700 10.1016/S0278-5846(03)00080-0 12787858 10.1016/S0278-5846(03)00080-0 1:CAS:528:DC%2BD3sXkt1KitLw%3D (Pubitemid 36645072)
3. D Ben-Shachar 2002 Mitochondrial dysfunction in schizophrenia: a possible linkage to dopamine J Neurochem 83 1241 1251 10.1046/j.1471-4159.2002.01263 12472879 10.1046/j.1471-4159.2002.01263.x 1:CAS:528:DC%2BD3sXjsFGr (Pubitemid 35477464)
4. D Ben-Shachar D Laifenfeld 2003 Mitochondria, synaptic plasticity, and schizophrenia Int Rev Neurobiol 59 273 296 10.1016/S0074-7742(04)59011-6 10.1016/S0074-7742(04)59011-6 (Pubitemid 39752419)
5. D Ben-Shachar O Bonne R Chisin E Klein H Lester J Aharon-Peretz, et al. 2007 Cerebral glucose utilization and platelet mitochondiral complex I activity in schizophrenia: a FDG-PET study Prog Neupsychopharmacol Biol Psychiatry 31 807 813 10.1016/j.pnpbp. 2006.12.025 10.1016/j.pnpbp.2006.12.025 1:CAS:528:DC%2BD2sXkvFGksL0%3D (Pubitemid 46671478)
6. MA Birch-Machin HL Briggs AA Saborido LA Bindoff DM Turnbull 1994 An evaluation of the measurement of the activities of complexes I-IV in the respiratory chain of human skeletal muscle mitochondria Biochem Med Metab Biol 51 35 42 0885-4505/94 8192914 10.1006/bmmb.1994.1004 1:CAS:528: DyaK2cXitlyktL8%3D (Pubitemid 24174862)
7. EJ Boekema HP Braun 2007 Supramolecular structure of the mitochondrial oxidative phosphorylation system J Biol Chem 282 1 4 10.1074/jbc.R600031200 17102127 10.1074/jbc.R600031200 1:CAS:528:DC%2BD2sXks1Km (Pubitemid 47076588)
8. CR Bowie PD Harvey 2006 Schizophrenia from a neuropsychiatric perspective Mt Sinai J Med 73 993 998 17195885 (Pubitemid 46040397)
9. RA Bressan LS Pilowsky 2003 Hipótese glutamatérgica da esquizofrenia Rev Bras Psiq 25 177 183 10.1590/S1516-44462003000300011
10. Bubber P, Hartounian V, Gibsin GE, Blass JP (2010) Abnormalities in the tricarboxylic acid (TCA) cycle in the brains of schizophrenia patients. Eur Neuropsychopharmacol 21:254-260. doi: 10.1016/j.euroneuro.2010.10.007
11. V Bubeníková-Valešová J Horáček M Vrajová C Höschl 2008 Models of schizophrenia in humans and animals based on inhibition of NMDA receptors Neurosci Biobehav Rev 38 1014 1023 10.1016/j.neubiorev.2008.03.012 10.1016/j.neubiorev.2008.03.012 (Pubitemid 351756510)
12. A Cassina R Radi 1996 Differential inhibitory action of nitric oxide and peroxynitrite on mitochondrial electron transport Arch Biochem Biophys 328 309 316 10.1006/abbi.1996.0178 8645009 10.1006/abbi.1996.0178 1:CAS:528: DyaK28Xit1Klt7w%3D (Pubitemid 26160113)
13. L Cavelier E Jazin I Eriksson J Prince U Bave L Oreland U Gyllensten 1995 Decreased cytochrome c oxidase activity and lack of age related accumulation of mtDNA in brain of schizophrenics Genomics 29 217 228 10.1006/geno.1995.1234 8530074 10.1006/geno.1995.1234 1:CAS:528:DyaK2MXotF2hurc%3D
14. De Padua AC, Gama CS, Lobato MI. Psicofármacos. Artmed POA. 2005.
15. S Di Donato 2000 Disorders related to mitochondrial membranes: phatology of the respiratory chain and neurodegeneration J Inheret Metab Dis 23 247 263 10.1023/A:1005684029429 10.1023/A:1005684029429 (Pubitemid 30330407)
16. GE Duncan JN Leipzig RB Mailman JA Lieberman 1998 Differential effects of clozapine and haloperidol on ketamine-induced brain metabolic activation Brain Res 812 65 75 10.1016/S0006-8993(98)00926-3 9813244 10.1016/S0006-8993(98)00926- 3 1:CAS:528:DyaK1cXntVyiu7c%3D (Pubitemid 29005332)
17. NB Farber DF Wozniak MT Price J Labruyere J Huss HS Peter JW Olney 1995 Age-specific neurotoxicity in the rat associated with NMDA receptor blockade: potential relevance to schizophrenia? Biol Psychiat 38 788 796 10.1016/0006-3223(95)00046-1 8750036 10.1016/0006-3223(95)00046-1 1:CAS:528:DyaK28XmsVWitw%3D%3D (Pubitemid 3020005)
18. O Fattal K Budur AJ Vaughan K Franco 2006 Review of the literature on major mental disorders in adult patients with mitochondrial diseases Psychosomat 47 1 7 10.1176/appi.psy.47.1.1 10.1176/appi.psy.47.1.1 (Pubitemid 43017115)
19. JC Fischer W Ruitenbeek JA Berden JM Trijbels JH Veerkamp AM Stadhouders, et al. 1985 Differential investigation of the capacity of succinate oxidation in human skeletal muscle Clin Chim Acta 153 23 26 3000647 10.1016/0009-8981(85) 90135-4 1:CAS:528:DyaL28Xhs1yhsw%3D%3D (Pubitemid 16200073)
20. A Hitri DA O'Connor JM Cohen DJ Keuler SI Deutsch 1993 Differentiation between MK-801-and apomorphine-induced stereotyped behaviors in mice Clin Neuropharmacol 16 220 236 8504439 10.1097/00002826-199306000-00006 1:STN:280:DyaK3s3nvVOjtw%3D%3D (Pubitemid 23149960)
21. MJ Hunt B Raynaud R Garcia 2006 Ketamine dose-dependently unduces high-frequency oscillations in the nucleus accumbens in freely moving rats Biol Psychiat 60 1206 1214 10.1016/j.biopsych.2006.01.020 16650831 10.1016/j.biopsych.2006.01.020 1:CAS:528:DC%2BD28Xht1Shtb%2FM (Pubitemid 44693529)
22. R Karry E Klein D Ben-Shachar 2004 Mitochondrial complex I subunits expression is altered in schizophrenia: a postmortem study Biol Psychiatry 55 676 684 10.1016/j.biopsych.2003.12.012 15038995 10.1016/j.biopsych.2003.12.012 1:CAS:528:DC%2BD2cXisVegsrg%3D (Pubitemid 38376178)
23. JH Krystal LP Karper JP Seibyl GF Freeman R Delaney JD Bremner 1994 Subanesthetic effects of the noncompetitive NMDA antagonists, ketamine, in humans Arch Gen Psychiatry 51 199 214 8122957 1:CAS:528:DyaK2cXkslemtrY%3D
24. L Kung RC Roberts 1999 Mitochondrial pathology in human schizophrenic striatum: a postmortem ultrastructural study Synapse 31 67 75 10025685 10.1002/(SICI)1098-2396(199901)31:1<67::AID-SYN9>3.0.CO;2-# 1:CAS:528:DyaK1cXnvFOgt7s%3D (Pubitemid 29009281)
25. DA Lewis JA Lieberman 2000 Catching up on schizophrenia: natural history and neurobiology Neuron 28 325 334 10.1016/S0896-6273(00)00111-2 11144342 10.1016/S0896-6273(00)00111-2 1:CAS:528:DC%2BD3cXoslais7g%3D
26. BK Lipska DR Weinberger 2000 To model a psychiatric disorder in animals: schizophrenia as a reality test Neuropsychopharmacol 23 223 239 10.1038/sj.npp. 1395545 10.1016/S0893-133X(00)00137-8 1:STN:280:DC%2BD3cvotVejtg%3D%3D (Pubitemid 30609657)
27. CL Littlewood N Jones MJ O'Neill SN Mitchell M Tricklebank SCR Williams 2006 Mapping the central effects of ketamine in the rat using pharmacological MRI Psychopharmacol 186 64 81 10.1007/s00213-006-0344-0 1:CAS:528: DC%2BD28XjslGisbY%3D (Pubitemid 43668312)
28. OH Lowry NJ Rosebrough AL Farr RJ Randall 1951 Protein measurement with the Folin phenol reagent J Biol Chem 193 265 267 14907713 1:CAS:528: DyaG38XhsVyrsw%3D%3D
29. ER Marcotte DM Pearson LK Srivastava 2001 Animal models of schizophrenia: a critical review J Psychiatry Neurosci 26 395 410 11762207 1:STN:280:DC%2BD38%2Fjs1Sjuw%3D%3D (Pubitemid 34082728)
30. I Maurer HJ Moller 1997 Inhibition of complex I by neuroleptics in normal human brain cortex parallels the extrapyramidal toxicity of neuroleptics Mol Cell Biochem 174 255 259 10.1023/A:1006872911332 9309697 10.1023/A:1006872911332 1:CAS:528:DyaK2sXmt1equ7w%3D (Pubitemid 27404200)
31. I Maurer S Zierz HJ Möller 2001 Evidence for a mitochondrial oxidative phosphorylation defect in brains from patients with schizophrenia Schizophr Res 48 125 136 10.1016/S0920-9964(00)00075-X 11278159 10.1016/S0920-9964(00)00075-X 1:STN:280:DC%2BD3M7ovF2mtg%3D%3D (Pubitemid 32241188)
32. JC Maxwell 2005 Party Drugs: properties, prevalence, patterns and problems Subst Use Misus 40 1203 1240 10.1081/JA-200066736 10.1081/JA-200066736 (Pubitemid 41102237)
33. HY Meltzer B Bastani L Ramirez S Matsubara 1989 Clozapine: new research on efficacy and mechanism of action Eur Arch Psychiatry Neurol Sci 238 332 339 2569975 10.1007/BF00449814 1:STN:280:DyaL1Mzls1Omtw%3D%3D (Pubitemid 19184632)
34. JM Meyer 2007 Antipsychotic safety and efficacy concerns J Clin Psychiatry 68 20 26 18284274 10.4088/JCP.0807e20
35. SS Nikam AK Awasthi 2008 Evolution of schizophrenia drugs: a focus on dopaminergic systems Curr Opin Investig Drugs 9 37 46 18183530 1:CAS:528:DC%2BD1cXitVOgtr8%3D
36. S Park PS Holzman 1992 Schizophrenics show spatial working memory deficits Arch Gen Psychiatry 49 975 982 1449384 1:STN:280:DyaK3s%2FotVCmsg%3D%3D
37. S Prabakaran JE Swatton MM Ryan SJ Huffaker JTJ Huang JL Griffin 2004 Mitochondrial dysfunction in schizophrenia: evidence for compromised brain metabolism and oxidative stress Mol Psychiatry 9 684 697 10.1038/sj.mp. 4001511 15098003 10.1038/sj.mp.4001532 1:CAS:528:DC%2BD2cXltFWntLs%3D (Pubitemid 38932173)
38. JA Prince K Blennow CG Gottfries I Karlsson L Oreland 1997 Mitochondrial function in differentially altered in the basal ganglia of chronic schizophrenics Neuropsychopharmacol 21 372 379 S0893-133X(99)00016-0 10.1016/S0893-133X(99)00016-0 (Pubitemid 29333075)
39. PH Reddy 2008 Mitochondrial medicine for aging and neurodegenerative diseases Neuromolecular Med. 10 291 315 18566920 10.1007/s12017-008-8044-z 1:CAS:528:DC%2BD1MXhtlKktQ%3D%3D
40. PH Reddy 2009 Role of mitochondria in neurodegenerative diseases: mitochondria as a therapeutic target in Alzheimer's disease CNS Spectr 14 8 13 19890241
41. GT Rezin G Amboni AI Zugno J Quevedo EL Streck 2008 Mitchondrial dysfunction and psychiatric disorders Neurochem Res 34 1021 1029 10.1007/s11064-008-9865-8 18979198 10.1007/s11064-008-9865-8
42. GS Robertson SE Hori KJ Powell 2006 Schizophrenia: an integrative approach to modelling a complex disorder J Psyc Neurosci 31 157 167 (Pubitemid 43954734)
43. P Rustin D Chretien T Bourgeron B Gérard A Rötig JM Saudubray A Munnich 1994 Biochemical and molecular investigations in respiratory chain deficiencies Clin Chim Acta 228 35 51 7955428 10.1016/0009-8981(94)90055-8 1:CAS:528:DyaK2cXltlWjsLc%3D (Pubitemid 24231224)
44. C Strazielle C Sturchler-Pierrat M Staufenbiel R Lalonde 2003 Regional brain cytochrome oxidase activity in beta-amyloid precursor protein transgenic mice with the Swedish mutation Neurosc 118 1151 1163 10.1016/S0306-4522(03) 00037-X 10.1016/S0306-4522(03)00037-X 1:CAS:528:DC%2BD3sXjsVejsL8%3D (Pubitemid 36561201)
45. NR Swerdlow V Bakshi M Waikar N Taad MA Geyer 1998 Seroquel, clozapine and chlorpromazine restore sensorimotor gating in ketamine-treated rats Psychopharmacol 140 75 80 10.1007/s002130050741 10.1007/s002130050741 1:CAS:528:DyaK1cXnvFOks7g%3D (Pubitemid 28524310)
46. K Takeyama M Yoshikawa T Oka M Kawaguchi T Suzuki A Hashimoto 2006 Ketamine enhances the expression of serine racemase and D-amino acid oxidase mRNAs in rat brain Eur J Pharmacol 540 82 86 10.1016/j.ejphar.2006.04.021 16716293 10.1016/j.ejphar.2006.04.021 1:CAS:528:DC%2BD28XmtVOnt7Y%3D (Pubitemid 43866692)
47. AY Tien WW Eaton 1992 Psychopathologic precursors and sociodemographic risk factors for the schizophrenia syndrome Arch Gen Psychiatry 49 37 46 1728250 1:STN:280:DyaK38%2FpsFOrtQ%3D%3D
48. N Uranova D Orlovskaya O Vikhreva I Zimina N Kolomeets V Vostrikov, et al. 2001 Electron microscopy of oligodendroglia in severe mental illness Brain Res Bull 55 597 610 10.1016/S0361-9230(01)00528-7 11576756 10.1016/S0361- 9230(01)00528-7 1:STN:280:DC%2BD3MrjtVWhsg%3D%3D (Pubitemid 32888378)
49. M Van Den Buuse B Garner A Gogos S Kusljic 2005 Importance of animal models in schizophrenia research Aust N Z J Psychiatry 39 550 557 15996135 (Pubitemid 41602539)
50. SJ Wood M Yücel C Pantelis M Berk 2009 Neurobiology of schizophrenia spectrum disorders: the role of oxidative stress Ann Acad Med Singapore 38 396 401 19521638